Tracking the strong leads from the US markets overnight and Asian peers, the indices are set to open on a positive note. At the time of writing, SGX Nifty was trading higher by 10 points at 11,958 level.

Lupin has received approval for its Phenylephrine and Ketorolac Intraocular Solution from USFDA. The shares of the company however traded in red reacting to the news, on Wednesday.

Several attempts have been made at studying the wealth necessary for happiness. These studies warrant consideration not because they agree on a specific number, but because they attempt to measure how much is necessary to be financially free.

The company has received an additional export order for 80,000 steel wheels for the EU Caravan trailer market. The company expects a record quarterly volume in Q2FY20.

In the latest government auction, Vedanta has won 10 oil and gas (O&G) exploration blocks and ONGC has won 8. Reacting to the development, the shares of ONGC gained, while Vedanta slid.

The stocks to watch out for July 4 include Lupin, Kotak Mahindra, GAIL, Steel Strips Wheels and Tech Mahindra.

USFDA has given the final approval to Zydus Cadila to market Misoprostol Tablets, 100 mcg and 200 mcg. The drug will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad.

GAIL (India) Ltd. successfully commissioned the 165 km Gorakhpur project under the Pradhan Mantri Urja Ganga (PMUG) national gas pipeline project.

Asian Granito India Ltd (AGIL) received a hearty response from the dealer meet organised during June 16 to July 2, 2019. The company has landed orders to the tune of Rs. 175 crore.

Dr. Reddy’s Laboratories Limited has announced the launch of Carboprost Tromethamine Injection USP, 250 mcg/mL (1mL) Single-dose Vial, a therapeutic equivalent generic version of Hemabate injection, 250 mcg/mL, approved by the US Food and Drug Administration (USFDA).